• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tracing and control of raw materials sourcing for vaccine manufacturers.

作者信息

Faretra Peysson Laurence

机构信息

BD Diagnostics-Diagnostic Systems, 11 Rue Aristide Bergès, BP 4, 38801 Le Pont de Claix Cédex, France.

出版信息

Biologicals. 2010 May;38(3):352-3. doi: 10.1016/j.biologicals.2010.01.011. Epub 2010 Mar 23.

DOI:10.1016/j.biologicals.2010.01.011
PMID:20335052
Abstract

The control of the raw materials used to manufacture vaccines is mandatory; therefore, a very clear process must be in place to guarantee that raw materials are traced. Those who make products or supplies used in vaccine manufacture (suppliers of culture media, diagnostic tests, etc.) must apply quality systems proving that they adhere to certain standards. ISO certification, Good Manufacturing Practices for production sites and the registration of culture media with a 'Certificate of Suitability' from the European Directorate for the Quality of Medicines and Healthcare are reliable quality systems pertaining to vaccine production. Suppliers must assure that each lot of raw materials used in a product that will be used in vaccine manufacture adheres to the level of safety and traceability required. Incoming materials must be controlled in a single 'Enterprise Resource Planning' system which is used to document important information, such as the assignment of lot number, expiration date, etc. Ingredients for culture media in particular must conform to certain specifications. The specifications that need to be checked vary according to the ingredient, based on the level of risk. The way a raw material is produced is also important, and any aspect relative to cross-contamination, such as the sanitary measures used in producing and storing the raw material must be checked as well. In addition, suppliers can reduce the risk of viral contamination of raw materials by avoiding purchases in countries where a relevant outbreak is currently declared.

摘要

相似文献

1
Tracing and control of raw materials sourcing for vaccine manufacturers.
Biologicals. 2010 May;38(3):352-3. doi: 10.1016/j.biologicals.2010.01.011. Epub 2010 Mar 23.
2
Low levels of extraneous agents in vaccine starting materials.
Biologicals. 2010 May;38(3):354-7. doi: 10.1016/j.biologicals.2010.01.004. Epub 2010 Mar 26.
3
Transmissible spongiform encephalopathies (TSE): minimizing the risk of transmission by biological/biopharmaceutical products: an industry perspective.可传播性海绵状脑病(TSE):通过生物/生物制药产品将传播风险降至最低:行业视角
Dev Biol Stand. 1996;88:257-64.
4
Considerations for setting the specifications of vaccines.疫苗规格设定的注意事项。
Expert Rev Vaccines. 2012 May;11(5):579-85. doi: 10.1586/erv.12.23.
5
[Microbiological in-process control in drug manufacture].
Arzneimittelforschung. 1985;35(1A):205-16.
6
Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.禽类来源底物的外来因子检测及家禽病毒疫苗:现行规定与未来方法建议
Biologicals. 2010 May;38(3):362-5. doi: 10.1016/j.biologicals.2010.01.010. Epub 2010 Mar 23.
7
Adventitious agents from animal-derived raw materials--a method of risk assessment.
Dev Biol Stand. 1996;88:283-90.
8
Risk reduction in biotherapeutic products.生物治疗产品的风险降低
Curr Opin Drug Discov Devel. 2009 Mar;12(2):296-304.
9
Three Rs potential in the development and quality control of immunobiologicals.免疫生物学制品研发与质量控制中的“3R”潜力
ALTEX. 2001;18 Suppl 1:13-47.
10
WHO Expert Committee on Specifications for Pharmaceutical Preparations.世界卫生组织药物制剂规范专家委员会
World Health Organ Tech Rep Ser. 2011(961):1-428, back cover.

引用本文的文献

1
Blockchain and COVID-19 pandemic: applications and challenges.区块链与新冠疫情:应用与挑战
Cluster Comput. 2023 Apr 29:1-26. doi: 10.1007/s10586-023-04009-7.
2
Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction.非洲的疫苗生产:能力建设与可持续引入新疫苗的可行商业模式
Front Public Health. 2019 Mar 20;7:56. doi: 10.3389/fpubh.2019.00056. eCollection 2019.